申请人:Aventis Pharma S.A.
公开号:US20040138257A1
公开(公告)日:2004-07-15
The present invention relates to cancer therapy and to novel anticancer agents having a mechanism of action which is quite specific. It also relates to novel chemical compounds as well as their therapeutic application in humans.
本发明涉及癌症治疗和具有相当特异作用机制的新型抗癌药物。它还涉及新型化合物以及它们在人类中的治疗应用。